Leukemia & Lymphoma, Volume 52, Issue 10 (2011)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 52, Issue 10 (2011)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Volume 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

Article
Is there a role for consolidative radiation therapy for aggressive B-cell lymphoma in the rituximab era?
Andrea K. Ng & David C. Hodgson
Pages: 1821-1822
Published online: 23 Sep 2011
CitationforIs there a role for consolidative radiation therapy for aggressive B-cell lymphoma in the rituximab era? | Full Text | References | PDF (119.1 KB) | Supplemental
  • 575 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
Multi-parameter prognostication in chronic lymphocytic leukemia
Clive S. Zent
Pages: 1823-1824
Published online: 08 Jul 2011
CitationforMulti-parameter prognostication in chronic lymphocytic leukemia | Full Text | References | PDF (53.9 KB)
  • 441 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
High-dose methotrexate in patients with primary central nervous system lymphoma: does drug exposure really matter?
Markus Joerger, A. D. R. Huitema, G. Illerhaus & A. J. M Ferreri
Pages: 1825-1827
Published online: 10 Jun 2011
First Page PreviewforHigh-dose methotrexate in patients with primary central nervous system lymphoma: does drug exposure really matter? | Full Text | References | PDF (125.8 KB) | Supplemental
  • 882 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Are we improving the survival of patients with mantle cell lymphoma: if so, what is the explanation?
Andre Goy
Pages: 1828-1830
Published online: 24 Aug 2011
First Page PreviewforAre we improving the survival of patients with mantle cell lymphoma: if so, what is the explanation? | Full Text | References | PDF (62.1 KB)
  • 642 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Alemtuzumab (Campath-1H) for chronic lymphocytic leukemia: a drug in search of its optimal schedule
Tamar Tadmor
Pages: 1831-1833
Published online: 23 May 2011
First Page PreviewforAlemtuzumab (Campath-1H) for chronic lymphocytic leukemia: a drug in search of its optimal schedule | Full Text | References | PDF (56.1 KB) | Supplemental
  • 453 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Potential clinical application of imatinib mesylate in patients with leukemic large granular lymphocytes
Jun Yang & Thomas P. Loughran
Pages: 1834-1835
Published online: 24 Jun 2011
CitationforPotential clinical application of imatinib mesylate in patients with leukemic large granular lymphocytes | Full Text | References | PDF (118.1 KB) | Supplemental
  • 439 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Acquired immune-mediated thrombophilia in lymphoproliferative disorders
Klaus Lechner, Ingrid Simonitsch, Johanna Haselböck, Ulrich Jäger & Ingrid Pabinger
Pages: 1836-1843
Published online: 18 Jul 2011
AbstractforAcquired immune-mediated thrombophilia in lymphoproliferative disorders | Full Text | References | PDF (161 KB) | Supplemental
  • 517 Views
  • 17 CrossRef citations
  • 0Altmetric
Review Article
Role of gut microbiota in graft-versus-host disease
Stephen Murphy & Vu H. Nguyen
Pages: 1844-1856
Published online: 12 Jun 2011
AbstractforRole of gut microbiota in graft-versus-host disease | Full Text | References | PDF (416.9 KB) | Supplemental
  • 910 Views
  • 41 CrossRef citations
  • 0Altmetric
Review Article
The mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma
Joseph Gera & Alan Lichtenstein
Pages: 1857-1866
Published online: 23 May 2011
AbstractforThe mammalian target of rapamycin pathway as a therapeutic target in multiple myeloma | Full Text | References | PDF (431.1 KB) | Supplemental
  • 482 Views
  • 30 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Article
Radiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma
Luigi Marcheselli, Raffaella Marcheselli, Alessia Bari, ElianaValentina Liardo, Fortunato Morabito, Luca Baldini, Maura Brugiatelli, Francesco Merli, Nicola Di Renzo & Stefano Sacchi
Pages: 1867-1872
Published online: 12 Jun 2011
AbstractforRadiation therapy improves treatment outcome in patients with diffuse large B-cell lymphoma | Full Text | References | PDF (366.2 KB) | Supplemental
  • 608 Views
  • 42 CrossRef citations
  • 0Altmetric
Article
Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia
Douglas E. Gladstone, Lode Swinnen, Yvette Kasamon, Amanda Blackford, Christopher D. Gocke, Constance A. Griffin, Javier Bolanos Meade & Richard J. Jones
Pages: 1873-1881
Published online: 18 Aug 2011
AbstractforImportance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia | Full Text | References | PDF (349.5 KB) | Supplemental
  • 275 Views
  • 12 CrossRef citations
  • 0Altmetric

original article: Clinical

Article
High-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma
Lauren M. Gerard, Kevin R. Imrie, Joy Mangel, Rena Buckstein, Mary Doherty, Robert Mackenzie & Matthew C. Cheung
Pages: 1882-1890
Published online: 12 Jun 2011
AbstractforHigh-dose methotrexate based chemotherapy with deferred radiation for treatment of newly diagnosed primary central nervous system lymphoma | Full Text | References | PDF (223.3 KB)
  • 349 Views
  • 16 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy
Patrick G. Morris, Lauren E. Abrey, Anne S. Reiner, Nian Wu, Katherine S. Panageas, Brian S. Seko, Lisa M. Deangelis & Antonio Omuro
Pages: 1891-1897
Published online: 24 Jun 2011
AbstractforMethotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy | Full Text | References | PDF (370.5 KB) | Supplemental
  • 272 Views
  • 9 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Article
Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot study
Akiyoshi Miwa, Naohiro Sekiguchi, Akira Tanimura, Chiho Homma, Tateki Shikai, Yayoi Takezako, Noboru Yamagata & Naoki Takezako
Pages: 1898-1903
Published online: 08 Jun 2011
AbstractforRanimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot study | Full Text | References | PDF (140.9 KB) | Supplemental
  • 229 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Evaluation of prognostic values of clinical and histopathologic characteristics in diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy
Junshik Hong, Sanghui Park, Jinny Park, Hyung Sun Kim, Kyung-Hee Kim, Jeong Yeal Ahn, Min Young Rim, Minkyu Jung, Sun Jin Sym, Eun Kyung Cho, Dong Bok Shin & Jae Hoon Lee
Pages: 1904-1912
Published online: 30 Jun 2011
AbstractforEvaluation of prognostic values of clinical and histopathologic characteristics in diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy | Full Text | References | PDF (385.9 KB) | Supplemental
  • 341 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma
Ljubomir R. Jakovic, Biljana S. Mihaljevic, Maja D. Perunicic Jovanovic, Andrija D. Bogdanovic, Bosko M. Andjelic & Vladimir Z. Bumbasirevic
Pages: 1913-1919
Published online: 12 Jun 2011
AbstractforThe prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma | Full Text | References | PDF (715.5 KB) | Supplemental
  • 297 Views
  • 40 CrossRef citations
  • 0Altmetric

original article: Clinical

Article
Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network
Katrina Farrell, Pamela Mckay & Mike Leach
Pages: 1920-1928
Published online: 12 Jun 2011
AbstractforNodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network | Full Text | References | PDF (294.7 KB) | Supplemental
  • 340 Views
  • 22 CrossRef citations
  • 0Altmetric

Original article: clinical

Article
Marked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry
Anna Abrahamsson, Nina Dahle & Mats Jerkeman
Pages: 1929-1935
Published online: 24 Jun 2011
AbstractforMarked improvement of overall survival in mantle cell lymphoma: a population based study from the Swedish Lymphoma Registry | Full Text | References | PDF (237.9 KB) | Supplemental
  • 354 Views
  • 39 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Article
Multicenter study of subcutaneous alemtuzumab administered at reduced dose in patients with fludarabine-relapsed/refractory chronic lymphocytic leukemia: final analysis
Raimundo Fernando Bezares, German Stemelin, Alicia Diaz, Daniel Argentieri, Emilio Lanari Zubiaur, Guy Garay, Miguel Bartomioli, Ricardo Ryser & Gustavo Milone
Pages: 1936-1941
Published online: 30 Jun 2011
AbstractforMulticenter study of subcutaneous alemtuzumab administered at reduced dose in patients with fludarabine-relapsed/refractory chronic lymphocytic leukemia: final analysis | Full Text | References | PDF (258.1 KB) | Supplemental
  • 375 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
A randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant
Stefano Sacchi, Raffaella Marcheselli, Antonio Lazzaro, Fortunato Morabito, Alberto Fragasso, Nicola Di Renzo, Enrico Balleari, Santo Neri, Giovanni Quarta, Raimondo Ferrara, Maria Luigia Vigliotti, Giuseppe Polimeno, Pellegrino Musto, Ugo Consoli, Alessandra Zoboli, Gabriele Buda, Alessandro Pastorini & Luciano Masini
Pages: 1942-1948
Published online: 12 Jun 2011
AbstractforA randomized trial with melphalan and prednisone versus melphalan and prednisone plus thalidomide in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplant | Full Text | References | PDF (361 KB) | Supplemental
  • 722 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Methylenetetrahydrofolate reductase gene polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis based on 28 case–control studies
Na Tong, Xiaojing Sheng, Meilin Wang, Yongjun Fang, Danni Shi, Zhizhong Zhang & Zhengdong Zhang
Pages: 1949-1960
Published online: 24 Jun 2011
AbstractforMethylenetetrahydrofolate reductase gene polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis based on 28 case–control studies | Full Text | References | PDF (483.8 KB) | Supplemental
  • 220 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia
Maurizio Miglino, Nicoletta Colombo, Gianmatteo Pica, Raffaella Grasso, Marino Clavio, Micaela Bergamaschi, Filippo Ballerini, Anna Ghiso, Chiara Ghiggi, Laura Mitscheunig, Germana Beltrami, Antonia Cagnetta, Luana Vignolo, Maria Vita Lucchetti, Sara Aquino, Ivana Pierri, Mario Sessarego, Angelo Michele Carella & Marco Gobbi
Pages: 1961-1969
Published online: 23 Sep 2011
AbstractforWT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia | Full Text | References | PDF (416.1 KB) | Supplemental
  • 429 Views
  • 31 CrossRef citations
  • 0Altmetric

Original article: Research

Article
Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma
Maria Wysocka, Noor Dawany, Bernice Benoit, Andrew V. Kossenkov, Andrea B. Troxel, Joel M. Gelfand, Michael kelly Sell, Louise C. Showe & Alain H. Rook
Pages: 1970-1979
Published online: 23 Sep 2011
AbstractforSynergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma | Full Text | References | PDF (419.2 KB) | Supplemental
  • 281 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Development of imatinib and dasatinib resistance: dynamics of expression of drug transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1
Marta Gromicho, Joana Dinis, Marta Magalhães, Alexandra R. Fernandes, Purificação Tavares, António Laires, José Rueff & António Sebastião Rodrigues
Pages: 1980-1990
Published online: 12 Jun 2011
AbstractforDevelopment of imatinib and dasatinib resistance: dynamics of expression of drug transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1 | Full Text | References | PDF (787.4 KB) | Supplemental
  • 647 Views
  • 53 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation
Xudong Wang, Chang Li, Shaoqing Ju, Yueguo Wang, Huimin Wang & Renqian Zhong
Pages: 1991-1998
Published online: 30 Jun 2011
AbstractforMyeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation | Full Text | References | PDF (518.4 KB)
  • 644 Views
  • 76 CrossRef citations
  • 0Altmetric
Article
Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia
Dwella M. Nelson, Biju Joseph, Joelle Hillion, Jodi Segal, Judith E. Karp & Linda M. S. Resar
Pages: 1999-2006
Published online: 05 Jul 2011
AbstractforFlavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia | Full Text | References | PDF (317.3 KB)
  • 263 Views
  • 40 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Richter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia
Yngvar Fløisand, Jan Delabie, Alexander Fosså, Eirik Helseth, Eva A. Jacobsen, Jürgen Rolke & Geir E. Tjønnfjord
Pages: 2007-2009
Published online: 12 Jun 2011
First Page PreviewforRichter syndrome presenting as a solitary cerebellar tumor during first-line treatment for chronic lymphocytic leukemia | Full Text | References | PDF (232.1 KB) | Supplemental
  • 122 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Imatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease
Roberta Fedele, Massimo Martino, Antonella Dattola, Maria Cuzzola, Giuseppe Messina, Giuseppe Irrera & Pasquale Iacopino
Pages: 2010-2011
Published online: 12 Jun 2011
CitationforImatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease | Full Text | References | PDF (122.3 KB) | Supplemental
  • 107 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course
Fabio Forghieri, Monica Morselli, Leonardo Potenza, Monica Maccaferri, Letizia Pedrazzi, Valeria Coluccio, Patrizia Barozzi, Daniela Vallerini, Giovanni Riva, Eleonora Zanetti, Chiara Quarelli, Goretta Bonacorsi, Tullio Artusi, Piera Zaldini, Patrizia Zucchini, Roberto Marasca, Franco Narni, Brunangelo Falini, Giuseppe Torelli & Mario Luppi
Pages: 2012-2019
Published online: 03 Jun 2011
First Page PreviewforA case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course | Full Text | References | PDF (1.1 MB) | Supplemental
  • 112 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Association of aneuploidy category with centrosome amplification in multiple myeloma
Fedor Kryukov, Elena Dementyeva, Jan Smetana, Sabina Sevcikova, Petr Kuglik & Roman Hajek
Pages: 2020-2022
Published online: 03 Jun 2011
First Page PreviewforAssociation of aneuploidy category with centrosome amplification in multiple myeloma | Full Text | References | PDF (168.4 KB) | Supplemental
  • 88 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Rapid quantification of JAK2 V617F allele burden using a bead-based liquid assay with locked nucleic acid-modified oligonucleotide probes
Velizar Shivarov, Milena Ivanova, Evgueniy Hadjiev & Elissaveta Naumova
Pages: 2023-2026
Published online: 24 Jun 2011
First Page PreviewforRapid quantification of JAK2 V617F allele burden using a bead-based liquid assay with locked nucleic acid-modified oligonucleotide probes | Full Text | References | PDF (589.1 KB) | Supplemental
  • 115 Views
  • 9 CrossRef citations
  • 0Altmetric
Letter
Composite primary cutaneous peripheral T-cell lymphoma and Epstein–Barr virus-positive large B-cell lymphoma
Sheau-fang yang, Wen-Yu Chang, Cheng-Che E. Lan, Peter G. Isaacson & Shih-Sung Chuang
Pages: 2027-2030
Published online: 24 Jun 2011
First Page PreviewforComposite primary cutaneous peripheral T-cell lymphoma and Epstein–Barr virus-positive large B-cell lymphoma | Full Text | References | PDF (1.2 MB) | Supplemental
  • 136 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia
Christian Wilhelm, Andreas Neubauer & Andreas Burchert
Pages: 2031-2035
Published online: 24 Jun 2011
First Page PreviewforPoor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia | Full Text | References | PDF (116.7 KB) | Supplemental
  • 81 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles